Clinical Trials Study
Copyright ©2014 Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. May 21, 2014; 20(19): 5875-5880
Published online May 21, 2014. doi: 10.3748/wjg.v20.i19.5875
Prognostic significance of SUVmax and serum carbohydrate antigen 19-9 in pancreatic cancer
Jian-Guo Zhao, Ya Hu, Quan Liao, Zhe-Yu Niu, Yu-Pei Zhao
Jian-Guo Zhao, Ya Hu, Quan Liao, Zhe-Yu Niu, Yu-Pei Zhao, Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China
Author contributions: Liao Q and Zhao YP designed research; Zhao JG and Niu ZY performed research; Hu Y analyzed data; Zhao JG wrote the paper.
Supported by Fundamental Research Funds for the Central Universities of China, No. 2012N01
Correspondence to: Quan Liao, MD, Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 1 Shuai Fu Yuan Hu Tong, Beijing 100730, China. lqpumc@126.com
Telephone: +86-10-69156007 Fax: +86-10-69156007
Received: December 24, 2013
Revised: February 11, 2014
Accepted: March 6, 2014
Published online: May 21, 2014
Processing time: 145 Days and 2 Hours
Core Tip

Core tip: We investigated the clinicopathological characteristics and prognostic significance of standardized maximum uptake value (SUVmax) of pancreatic cancer and serum carbohydrate antigen (CA)19-9. Higher SUVmax or CA19-9 showed worse prognosis, and high serum CA19-9 plus SUVmax was the most significant variable in predicting survival.